Loto Biotech Platform, a near L’Aquila, Italy-based biotech startup, raised €600K in funding.
Scientifica Venture Capital made the investment.
The company intends to use the funds to expand operations and its development efforts.
Founded by Mattia Capulli, Isabella Baldini, Riccardo Paone, Loto Biotech is a biotech startup developing a proprietary AI-driven platform to design siRNA-based pro-drugs for rare genetic disorders, with a focus on autosomal dominant diseases.
The company is based at Tecnopolo D’Abruzzo. The team will further develop their technology within Scientifica Lab, a 4,000 m² space.
FinSMEs
30/06/2025
